|
1
|
Bardeesy N and DePinho RA: Pancreatic
cancer biology and genetics. Nat Rev Cancer. 2:897–909. 2002.
View Article : Google Scholar
|
|
2
|
Curran S and Murray GI: Matrix
metalloproteinases: molecular aspects of their roles in tumour
invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takeichi M: Cadherins in cancer:
implications for invasion and metastasis. Curr Opin Cell Biol.
5:806–811. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lugli A, Spichtin H, Maurer R, et al:
EphB2 expression across 138 human tumor types in a tissue
microarray: high levels of expression in gastrointestinal cancers.
Clin Cancer Res. 11:6450–6458. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walker-Daniels J, Hess AR, Hendrix MJ and
Kinch MS: Differential regulation of EphA2 in normal and malignant
cells. Am J Pathol. 162:1037–1042. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Héroult M, Schaffner F and Augustin HG:
Eph receptor and ephrin ligand-mediated interactions during
angiogenesis and tumor progression. Exp Cell Res. 312:642–650.
2006.PubMed/NCBI
|
|
7
|
Gale NW, Holland SJ, Valenzuela DM, et al:
Eph receptors and ligands comprise two major specificity subclasses
and are reciprocally compartmentalized during embryogenesis.
Neuron. 17:9–19. 1996. View Article : Google Scholar
|
|
8
|
Oki M, Yamamoto H, Taniguchi H, Adachi Y,
Imai K and Shinomura Y: Overexpression of the receptor tyrosine
kinase EphA4 in human gastric cancers. World J Gastroenterol.
14:5650–5656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oshima T, Akaike M, Yoshihara K, et al:
Overexpression of EphA4 gene and reduced expression of EphB2 gene
correlates with liver metastasis in colorectal cancer. Int J Oncol.
33:573–577. 2008.PubMed/NCBI
|
|
10
|
Bloomston M, Zervos EE and Rosemurgy AS
II: Matrix metalloproteinases and their role in pancreatic cancer:
A review of preclinical studies and clinical trials. Ann Surg
Oncol. 9:668–674. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dodelet VC and Pasquale EB: Eph receptors
and ephrin ligands: embryogenesis to tumorigenesis. Oncogene.
19:5614–5619. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu Z, Zhang Y, Li Z, et al: Overexpression
of the B-type Eph and ephrin genes correlates with progression and
pain in human pancreatic cancer. Oncol Lett. 3:1207–1212.
2012.PubMed/NCBI
|
|
14
|
Pasquale EB: Eph receptors and ephrins in
cancer: bidirectional signalling and beyond. Nat Rev Cancer.
10:165–180. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan P, Liu Y, Yu C, et al: EphA2 silencing
in nasopharyngeal carcinoma leads to decreased proliferation,
invasion and increased sensitization to paclitaxel. Oncol Lett.
4:429–434. 2012.PubMed/NCBI
|
|
16
|
Singh A, Winterbottom E and Daar IO:
Eph/ephrin signaling in cell-cell and cell-substrate adhesion.
Front Biosci (Landmark Ed). 17:473–497. 2012. View Article : Google Scholar
|
|
17
|
Giaginis C, Tsourouflis G,
Zizi-Serbetzoglou A, et al: Clinical significance of ephrin
(eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal
adenocarcinoma. Pathol Oncol Res. 16:267–276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyazaki K, Inokuchi M, Takagi Y, Kato K,
Kojima K and Sugihara K: EphA4 is a prognostic factor in gastric
cancer. BMC Clin Pathol. 13:192013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iiizumi M, Hosokawa M, Takehara A, et al:
EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma,
promotes cancer cell growth. Cancer Sci. 97:1211–1216. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukai J, Yokote H, Yamanaka R, Arao T,
Nishio K and Itakura T: EphA4 promotes cell proliferation and
migration through a novel EphA4-FGFR1 signaling pathway in the
human glioma U251 cell line. Mol Cancer Ther. 7:2768–2778. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
22
|
Duxbury MS, Ito H, Zinner MJ, Ashley SW
and Whang EE: Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic
adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun.
320:1096–1102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
von Burstin J, Eser S, Paul MC, et al:
E-Cadherin regulates metastasis of pancreatic cancer in vivo and is
suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
Gastroenterology. 137:361–371. 2009.PubMed/NCBI
|
|
24
|
Yan Y, Luo YC, Wan HY, et al: MicroRNA-10a
is involved in the metastatic process by regulating Eph tyrosine
kinase receptor A4-mediated epithelial-mesenchymal transition and
adhesion in hepatoma cells. Hepatology. 57:667–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
